Kenneth Olson
2021
In 2021, Kenneth Olson earned a total compensation of $704.3K as Chief Operating Officer at Harvard Bioscience, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $98,600 |
|---|---|
| Salary | $290,000 |
| Stock Awards | $290,000 |
| Other | $25,711 |
| Total | $704,311 |
Olson received $290K in salary, accounting for 41% of the total pay in 2021.
Olson also received $98.6K in non-equity incentive plan, $290K in stock awards and $25.7K in other compensation.
Rankings
In 2021, Kenneth Olson's compensation ranked 9,868th out of 12,405 executives tracked by ExecPay. In other words, Olson earned more than 20.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,868 out of 12,405 | 21st |
Division Manufacturing | 4,363 out of 5,494 | 21st |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 584 out of 798 | 27th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 158 out of 206 | 23rd |
Industry Laboratory Analytical Instruments | 75 out of 90 | 17th |
Source: SEC filing on April 7, 2022.
Olson's colleagues
We found two more compensation records of executives who worked with Kenneth Olson at Harvard Bioscience in 2021.